BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:32 PM
 | 
Aug 21, 2012
 |  BC Extra  |  Company News

FDA delays tofacitinib decision

FDA extended the PDUFA date by three months for an NDA from Pfizer Inc. (NYSE:PFE) for tofacitinib to treat rheumatoid...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >